List of Excipients in API fentanyl transdermal
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing fentanyl transdermal
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| SpecGx LLC | fentanyl transdermal | 0406-9025 | DIMETHICONE |
| SpecGx LLC | fentanyl transdermal | 0406-9025 | DIMETHICONE 350 |
| SpecGx LLC | fentanyl transdermal | 0406-9025 | DIPROPYLENE GLYCOL |
| SpecGx LLC | fentanyl transdermal | 0406-9025 | ETHYLENE-VINYL ACETATE COPOLYMER |
| SpecGx LLC | fentanyl transdermal | 0406-9025 | HEPTANE |
| SpecGx LLC | fentanyl transdermal | 0406-9025 | HYDROXYPROPYL CELLULOSE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for fentanyl transdermal
Excipient focus: DIMETHICONE
fentanyl transdermal drug variants containing DIMETHICONE
fentanyl transdermal drug variants not containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: DIMETHICONE 350
fentanyl transdermal drug variants containing DIMETHICONE 350
fentanyl transdermal drug variants not containing DIMETHICONE 350
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: DIPROPYLENE GLYCOL
fentanyl transdermal drug variants containing DIPROPYLENE GLYCOL
fentanyl transdermal drug variants not containing DIPROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYLENE-VINYL ACETATE COPOLYMER
fentanyl transdermal drug variants containing ETHYLENE-VINYL ACETATE COPOLYMER
fentanyl transdermal drug variants not containing ETHYLENE-VINYL ACETATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HEPTANE
fentanyl transdermal drug variants containing HEPTANE
fentanyl transdermal drug variants not containing HEPTANE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
fentanyl transdermal drug variants containing HYDROXYPROPYL CELLULOSE
fentanyl transdermal drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
